Macrophage-mesenchymal crosstalk in recurrent glioblastoma: a perspective for therapeutic strategies.
Glioblastoma (GBM) remains one of the most lethal cancers, with recurrence in nearly all patients despite standard therapy. However, the biological mechanisms governing recurrence remain incompletely understood. Increasing evidence suggests that recurrence is driven not only by tumor-intrinsic resistance, but also by d...